The cell lines SNU-878, SNU-886, SNU-398, CAL-72, and PEER were screened for kinase inhibitors using a kinase inhibitor-focused library (LINCS). The LINCS library contained 197 kinase inhibitors, from a diverse ATP competitive kinase inhibitor set. These kinase inhibitors were shown to be relatively potent and selective towards a narrow range of targets. 2000 adherent cells and 3000 suspension cells were plated with 50 μL medium in each well of a 384 microplate. Drugs with a concentration of 660 nM were added the same day. After 48 hours cellular proliferation was determined using CellTiter-Glo (Promega). Drugs identified as having a significant effect on this screen were tested in greater detail. 2000 adherent or 4000 suspension cells were plated on day 0 on a 96 well plate with 100 μL medium, except on the marginal wells. Drugs were added on day 1, which were serially diluted three-fold from 10 μM to 1.5 nM. Cell viability was determined after 72 hours of treatment by adding 20 μL CellTiter-Glo. Cell viability was determined using XLfit4.0 software. IC50 values were calculated using Graphpad Prism as the drug concentration that reduced cell viability by 50% compared to untreated cells. Rapamycin was purchased from LC laboratories and ganetespib from Synta Pharmaceuticals.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.